-
How a Tumor-Suppressing Protein Could Boost Head and Neck Cancer Immunity
Researchers at MD Anderson have identified a tumor-suppressing protein that is shut down by excess glutamine in head and neck cancers, blunting the immune response. Blocking glutamine metabolism restored immune activity in preclinical models, pointing to a new way to help resistant tumors respond to treatment.
-
Breast Cancer Drug Shows Promise Against Deadly Leukemia
Oregon Health & Science University researchers have identified a drug duo that could help people with acute myeloid leukemia overcome treatment resistance. By pairing a standard leukemia drug with a breast cancer medicine, the team saw stronger, longer-lasting anti-cancer effects in lab and animal studies.
-
‘Molecular Glue’ Drug Strategy Targets Resistant Lung Cancer
-
Experimental Drug NU-9 Blocks Early Alzheimer’s Damage in Mice
-
MIT mRNA Breakthrough Hints at Rejuvenating Aging Immune Systems
-
New ‘Plug-and-Play’ Immunotherapy May Boost Cancer Treatment
-
New Nanoparticle Strategy Boosts Precision of mRNA Cancer Vaccines
-
MSU Builds First Human Heart Organoid to Model Atrial Fibrillation
-
Fertility Gene Helps Brain Cancer Evade Chemo, Researchers Find
-
Scientists Pinpoint Enzyme That Fuels Treatment-Resistant Cancers